Print Article



This report focuses on corruption in the rollout of the COVID-19 vaccine in three different focus countries: Bangladesh, Uganda and Zambia. It aims to shed light on the prevalence of different types of corruption in relation to the rollout, discuss their potential drivers, as well as exploring prospective avenues for their prevention and mitigation.

The report reviews three types of corruption in regard to the COVID-19 vaccine rollout: bribery, corrupt fraud and embezzlement and diversion. Our analysis is based on primary data, reports and observations collected as part of our work in the three countries We triangulated findings with a systematic review of peer-reviewed literature as well as online news reports. The report aims to contribute to the rapidly developing evidence base on the COVID-19 vaccine rollout by offering a perspective that has so far often been overlooked and neglected: the widespread prevalence and adverse impact of corruption. Furthermore, it intends to expand our understanding of corruption in the health sector and offer some novel insights into the issue of corruption in vaccine delivery.

This research was made possible by funding from the Swedish Ministry of Foreign Affairs.


The Team

Meet the team of industry experts behind Comsure

Find out more

Latest News

Keep up to date with the very latest news from Comsure

Find out more


View our latest imagery from our news and work

Find out more


Think we can help you and your business? Chat to us today

Get In Touch

News Disclaimer

As well as owning and publishing Comsure's copyrighted works, Comsure wishes to use the copyright-protected works of others. To do so, Comsure is applying for exemptions in the UK copyright law. There are certain very specific situations where Comsure is permitted to do so without seeking permission from the owner. These exemptions are in the copyright sections of the Copyright, Designs and Patents Act 1988 (as amended)[]. Many situations allow for Comsure to apply for exemptions. These include 1] Non-commercial research and private study, 2] Criticism, review and reporting of current events, 3] the copying of works in any medium as long as the use is to illustrate a point. 4] no posting is for commercial purposes [payment]. (for a full list of exemptions, please read here]. Concerning the exceptions, Comsure will acknowledge the work of the source author by providing a link to the source material. Comsure claims no ownership of non-Comsure content. The non-Comsure articles posted on the Comsure website are deemed important, relevant, and newsworthy to a Comsure audience (e.g. regulated financial services and professional firms [DNFSBs]). Comsure does not wish to take any credit for the publication, and the publication can be read in full in its original form if you click the articles link that always accompanies the news item. Also, Comsure does not seek any payment for highlighting these important articles. If you want any article removed, Comsure will automatically do so on a reasonable request if you email